Methylphenidate Hydrochloride 13107-0380-01
- Manufacturer
- Aurolife Pharma, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- April 11, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA209276
Active Ingredients
| Ingredient | Strength |
|---|---|
| Methylphenidate Hydrochloride | 5 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
13107-0380-01Selected100 TABLET in 1 BOTTLE (13107-380-01)